| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| AIDS-Associated Nephropathy | 69 | 2022 | 82 | 11.850 |
Why?
|
| HIV-1 | 78 | 2022 | 653 | 7.240 |
Why?
|
| Podocytes | 21 | 2020 | 120 | 3.300 |
Why?
|
| Kidney | 66 | 2020 | 2146 | 3.240 |
Why?
|
| HIV Infections | 34 | 2022 | 2134 | 2.190 |
Why?
|
| Kidney Diseases | 20 | 2013 | 691 | 1.830 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 10 | 2014 | 43 | 1.690 |
Why?
|
| Kidney Glomerulus | 12 | 2020 | 156 | 1.410 |
Why?
|
| Kidney Failure, Chronic | 17 | 2020 | 960 | 1.340 |
Why?
|
| Mice, Transgenic | 50 | 2022 | 4143 | 1.200 |
Why?
|
| Anti-HIV Agents | 12 | 2010 | 350 | 1.100 |
Why?
|
| Acquired Immunodeficiency Syndrome | 11 | 2015 | 362 | 1.030 |
Why?
|
| Gene Products, vpr | 4 | 2022 | 24 | 1.010 |
Why?
|
| Gene Products, nef | 6 | 2006 | 15 | 0.930 |
Why?
|
| Immunoglobulin G | 4 | 2010 | 1021 | 0.880 |
Why?
|
| Ion Channels | 4 | 2008 | 212 | 0.880 |
Why?
|
| Antiretroviral Therapy, Highly Active | 9 | 2015 | 317 | 0.840 |
Why?
|
| Animals | 125 | 2022 | 59536 | 0.800 |
Why?
|
| Molecular Motor Proteins | 5 | 2014 | 36 | 0.760 |
Why?
|
| Myosin Heavy Chains | 6 | 2014 | 128 | 0.750 |
Why?
|
| Mice | 81 | 2022 | 34495 | 0.730 |
Why?
|
| Kidney Tubules | 10 | 2012 | 137 | 0.720 |
Why?
|
| Membrane Proteins | 8 | 2014 | 2819 | 0.710 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 7 | 2014 | 18 | 0.690 |
Why?
|
| Actins | 3 | 2014 | 608 | 0.680 |
Why?
|
| Glomerular Mesangium | 7 | 1999 | 40 | 0.670 |
Why?
|
| Genes, Viral | 8 | 2008 | 202 | 0.660 |
Why?
|
| Disease Models, Animal | 23 | 2022 | 7222 | 0.550 |
Why?
|
| Hypertension, Renovascular | 8 | 1996 | 22 | 0.550 |
Why?
|
| Malate Dehydrogenase | 2 | 2008 | 21 | 0.550 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2013 | 330 | 0.540 |
Why?
|
| Gene Expression | 18 | 2013 | 3570 | 0.540 |
Why?
|
| Kidney Tubules, Proximal | 5 | 2011 | 142 | 0.520 |
Why?
|
| Cytosol | 2 | 2008 | 238 | 0.520 |
Why?
|
| Transforming Growth Factor beta | 12 | 2004 | 1130 | 0.500 |
Why?
|
| Kidney Transplantation | 14 | 2020 | 755 | 0.500 |
Why?
|
| Gene Expression Regulation, Viral | 10 | 2011 | 187 | 0.480 |
Why?
|
| Nonmuscle Myosin Type IIA | 3 | 2012 | 7 | 0.480 |
Why?
|
| Internal Medicine | 3 | 2011 | 124 | 0.480 |
Why?
|
| Reverse Transcriptase Inhibitors | 2 | 2007 | 61 | 0.470 |
Why?
|
| Cells, Cultured | 20 | 2018 | 5637 | 0.460 |
Why?
|
| Neointima | 1 | 2013 | 53 | 0.460 |
Why?
|
| Glycoproteins | 4 | 2013 | 747 | 0.450 |
Why?
|
| Extracellular Matrix Proteins | 7 | 1998 | 315 | 0.440 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2010 | 460 | 0.440 |
Why?
|
| Animals, Genetically Modified | 2 | 2009 | 406 | 0.430 |
Why?
|
| Renal Circulation | 10 | 1994 | 60 | 0.430 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2013 | 160 | 0.410 |
Why?
|
| Cell Adhesion Molecules | 3 | 2010 | 577 | 0.410 |
Why?
|
| Humans | 133 | 2022 | 261506 | 0.400 |
Why?
|
| Virus Replication | 9 | 2011 | 709 | 0.390 |
Why?
|
| Teaching Rounds | 1 | 2011 | 33 | 0.390 |
Why?
|
| DNA-Binding Proteins | 8 | 2018 | 4821 | 0.390 |
Why?
|
| RNA, Messenger | 23 | 2014 | 6150 | 0.390 |
Why?
|
| Genetic Therapy | 6 | 2008 | 1616 | 0.390 |
Why?
|
| Laminin | 10 | 1996 | 194 | 0.380 |
Why?
|
| Anti-Retroviral Agents | 3 | 2008 | 148 | 0.380 |
Why?
|
| Juxtaglomerular Apparatus | 4 | 1994 | 7 | 0.380 |
Why?
|
| Gene Expression Regulation | 10 | 2014 | 4053 | 0.380 |
Why?
|
| Rats | 31 | 2006 | 6086 | 0.370 |
Why?
|
| Renin | 12 | 1996 | 92 | 0.360 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2018 | 1439 | 0.360 |
Why?
|
| DNA, Viral | 7 | 2009 | 694 | 0.360 |
Why?
|
| Muscle Proteins | 2 | 2018 | 549 | 0.360 |
Why?
|
| Caspase 8 | 1 | 2010 | 145 | 0.360 |
Why?
|
| Genes, nef | 2 | 2008 | 4 | 0.360 |
Why?
|
| Thromboxanes | 5 | 1992 | 12 | 0.360 |
Why?
|
| Ubiquitins | 2 | 2009 | 86 | 0.360 |
Why?
|
| Microvilli | 5 | 2005 | 83 | 0.350 |
Why?
|
| Captopril | 8 | 1996 | 34 | 0.340 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 7 | 2013 | 257 | 0.340 |
Why?
|
| Molecular Sequence Data | 19 | 2010 | 6089 | 0.330 |
Why?
|
| Cell Movement | 2 | 2013 | 2466 | 0.330 |
Why?
|
| Proteinuria | 9 | 2012 | 155 | 0.330 |
Why?
|
| Tretinoin | 3 | 2012 | 623 | 0.330 |
Why?
|
| Health Care Reform | 2 | 2009 | 68 | 0.330 |
Why?
|
| Integrins | 4 | 1994 | 262 | 0.320 |
Why?
|
| Collagen | 10 | 1999 | 752 | 0.320 |
Why?
|
| Cytokinesis | 1 | 2008 | 57 | 0.320 |
Why?
|
| Apoptosis | 9 | 2010 | 7591 | 0.320 |
Why?
|
| Transgenes | 8 | 2008 | 557 | 0.320 |
Why?
|
| Glomerular Filtration Rate | 12 | 2013 | 602 | 0.320 |
Why?
|
| Cyclic AMP | 3 | 2012 | 358 | 0.310 |
Why?
|
| Cardiomyopathies | 3 | 2018 | 610 | 0.310 |
Why?
|
| RNA, Viral | 10 | 2010 | 671 | 0.310 |
Why?
|
| Apolipoproteins | 3 | 2012 | 75 | 0.310 |
Why?
|
| Renal Artery Obstruction | 4 | 1994 | 38 | 0.310 |
Why?
|
| Calcium | 4 | 2005 | 1537 | 0.310 |
Why?
|
| Benzoxazines | 1 | 2007 | 27 | 0.300 |
Why?
|
| Transduction, Genetic | 3 | 2008 | 475 | 0.300 |
Why?
|
| Fibronectins | 8 | 1994 | 197 | 0.300 |
Why?
|
| Nucleic Acids | 2 | 2005 | 43 | 0.300 |
Why?
|
| Epithelial Cells | 10 | 2013 | 1818 | 0.300 |
Why?
|
| Polymerase Chain Reaction | 9 | 2010 | 3203 | 0.300 |
Why?
|
| Lipoproteins, HDL | 3 | 2012 | 144 | 0.300 |
Why?
|
| Cytoskeleton | 2 | 2008 | 267 | 0.290 |
Why?
|
| STAT3 Transcription Factor | 6 | 2013 | 1121 | 0.290 |
Why?
|
| Urine | 1 | 2007 | 143 | 0.290 |
Why?
|
| Proteomics | 1 | 2014 | 1380 | 0.290 |
Why?
|
| Renal Insufficiency, Chronic | 4 | 2022 | 787 | 0.290 |
Why?
|
| Rats, Inbred Strains | 14 | 1994 | 410 | 0.290 |
Why?
|
| Models, Animal | 2 | 2006 | 664 | 0.280 |
Why?
|
| Organophosphonates | 1 | 2007 | 64 | 0.280 |
Why?
|
| Cell Differentiation | 10 | 2012 | 4078 | 0.280 |
Why?
|
| Urban Health | 2 | 2007 | 75 | 0.270 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2011 | 5539 | 0.270 |
Why?
|
| Collagenases | 3 | 1996 | 74 | 0.260 |
Why?
|
| Blotting, Northern | 8 | 2007 | 682 | 0.260 |
Why?
|
| Renal Insufficiency | 3 | 2012 | 321 | 0.260 |
Why?
|
| Cell Division | 10 | 2013 | 2489 | 0.260 |
Why?
|
| src-Family Kinases | 2 | 2006 | 478 | 0.260 |
Why?
|
| Up-Regulation | 5 | 2018 | 2450 | 0.260 |
Why?
|
| RNA, Catalytic | 3 | 2004 | 37 | 0.250 |
Why?
|
| Base Sequence | 13 | 2007 | 4917 | 0.250 |
Why?
|
| Cell Adhesion | 9 | 2011 | 1008 | 0.250 |
Why?
|
| Fetus | 5 | 2000 | 601 | 0.250 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2008 | 280 | 0.240 |
Why?
|
| Glomerulonephritis | 5 | 2010 | 109 | 0.240 |
Why?
|
| HIV | 2 | 2020 | 229 | 0.240 |
Why?
|
| Lipid Bilayers | 3 | 2002 | 52 | 0.240 |
Why?
|
| Albuminuria | 4 | 2013 | 113 | 0.240 |
Why?
|
| Diabetic Nephropathies | 2 | 2018 | 183 | 0.240 |
Why?
|
| Adenine | 1 | 2007 | 631 | 0.230 |
Why?
|
| Cell Line | 11 | 2011 | 5114 | 0.230 |
Why?
|
| Thromboxane-A Synthase | 6 | 1992 | 22 | 0.230 |
Why?
|
| Risk Factors | 17 | 2022 | 17523 | 0.230 |
Why?
|
| Quality of Health Care | 1 | 2008 | 621 | 0.230 |
Why?
|
| Amino Acid Sequence | 10 | 2010 | 4233 | 0.220 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 2002 | 261 | 0.220 |
Why?
|
| Receptors, Angiotensin | 2 | 1994 | 44 | 0.220 |
Why?
|
| Cell Membrane | 5 | 2010 | 850 | 0.220 |
Why?
|
| Graft Rejection | 7 | 1999 | 834 | 0.220 |
Why?
|
| Angiotensin II | 5 | 1998 | 198 | 0.210 |
Why?
|
| MAP Kinase Signaling System | 1 | 2006 | 848 | 0.210 |
Why?
|
| Nephritis, Interstitial | 2 | 2011 | 76 | 0.210 |
Why?
|
| Nephrons | 1 | 2001 | 48 | 0.210 |
Why?
|
| Hypertension | 7 | 1998 | 1503 | 0.210 |
Why?
|
| Hypertension, Renal | 3 | 2012 | 30 | 0.210 |
Why?
|
| Delivery of Health Care | 2 | 2009 | 860 | 0.200 |
Why?
|
| Epoprostenol | 2 | 1993 | 75 | 0.200 |
Why?
|
| Lentivirus | 1 | 2002 | 169 | 0.200 |
Why?
|
| Genetic Vectors | 3 | 2002 | 1694 | 0.200 |
Why?
|
| Cell Proliferation | 8 | 2013 | 7226 | 0.190 |
Why?
|
| Disease Outbreaks | 3 | 2009 | 415 | 0.190 |
Why?
|
| Cyclosporins | 3 | 1990 | 112 | 0.190 |
Why?
|
| CD4 Lymphocyte Count | 5 | 2007 | 297 | 0.190 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2006 | 2063 | 0.190 |
Why?
|
| Flavonoids | 1 | 2001 | 188 | 0.190 |
Why?
|
| Potassium Deficiency | 2 | 1993 | 12 | 0.190 |
Why?
|
| Urothelium | 1 | 2002 | 254 | 0.190 |
Why?
|
| Prevalence | 8 | 2010 | 3260 | 0.190 |
Why?
|
| Cysts | 1 | 2001 | 197 | 0.180 |
Why?
|
| Zidovudine | 1 | 2000 | 40 | 0.180 |
Why?
|
| Cell Line, Transformed | 6 | 2013 | 394 | 0.180 |
Why?
|
| Purines | 1 | 2001 | 273 | 0.180 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2001 | 311 | 0.180 |
Why?
|
| Male | 57 | 2015 | 123000 | 0.180 |
Why?
|
| Thromboxane B2 | 7 | 1989 | 27 | 0.180 |
Why?
|
| Time Factors | 13 | 2013 | 12926 | 0.180 |
Why?
|
| Sirtuin 1 | 1 | 2020 | 89 | 0.180 |
Why?
|
| Oxygen Consumption | 3 | 2018 | 401 | 0.180 |
Why?
|
| Tissue Distribution | 5 | 2004 | 875 | 0.180 |
Why?
|
| Receptors, Retinoic Acid | 3 | 2012 | 365 | 0.180 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2013 | 224 | 0.180 |
Why?
|
| Microfilament Proteins | 5 | 2009 | 487 | 0.170 |
Why?
|
| Protein Biosynthesis | 1 | 2003 | 889 | 0.170 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2010 | 997 | 0.170 |
Why?
|
| Thymosin | 2 | 2010 | 29 | 0.170 |
Why?
|
| Global Health | 3 | 2009 | 657 | 0.170 |
Why?
|
| Cachexia | 3 | 1996 | 161 | 0.170 |
Why?
|
| Ureteral Obstruction | 3 | 1990 | 143 | 0.170 |
Why?
|
| DNA, Complementary | 3 | 2006 | 869 | 0.170 |
Why?
|
| WT1 Proteins | 3 | 2005 | 106 | 0.170 |
Why?
|
| Thromboxane A2 | 4 | 1993 | 21 | 0.160 |
Why?
|
| Mitochondria, Heart | 1 | 2018 | 72 | 0.160 |
Why?
|
| Cytokines | 2 | 2006 | 2809 | 0.160 |
Why?
|
| Phosphorylation | 7 | 2013 | 4804 | 0.160 |
Why?
|
| United States | 15 | 2011 | 15433 | 0.160 |
Why?
|
| In Situ Hybridization | 4 | 2006 | 1037 | 0.160 |
Why?
|
| Trans-Activators | 1 | 2004 | 1555 | 0.160 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2004 | 1498 | 0.160 |
Why?
|
| Adult | 38 | 2015 | 77950 | 0.160 |
Why?
|
| Apolipoprotein L1 | 3 | 2012 | 12 | 0.150 |
Why?
|
| Oligonucleotides, Antisense | 2 | 1996 | 248 | 0.150 |
Why?
|
| Biopsy | 8 | 2018 | 3443 | 0.150 |
Why?
|
| Transfection | 4 | 2013 | 2944 | 0.150 |
Why?
|
| Protein Precursors | 2 | 2010 | 240 | 0.150 |
Why?
|
| Renin-Angiotensin System | 1 | 1998 | 103 | 0.150 |
Why?
|
| Arachidonic Acids | 2 | 1988 | 29 | 0.150 |
Why?
|
| Signal Transduction | 9 | 2018 | 11965 | 0.150 |
Why?
|
| Transplant Recipients | 1 | 2020 | 324 | 0.150 |
Why?
|
| Oligonucleotides | 1 | 1998 | 227 | 0.150 |
Why?
|
| Human Immunodeficiency Virus Proteins | 2 | 2022 | 3 | 0.140 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2018 | 621 | 0.140 |
Why?
|
| Proteins | 2 | 2003 | 1963 | 0.140 |
Why?
|
| Piperidines | 1 | 2001 | 1035 | 0.140 |
Why?
|
| HIV Core Protein p24 | 1 | 1995 | 20 | 0.140 |
Why?
|
| HIV-2 | 1 | 1995 | 10 | 0.140 |
Why?
|
| Middle Aged | 33 | 2020 | 86204 | 0.140 |
Why?
|
| Ion Channel Gating | 1 | 1996 | 141 | 0.140 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2013 | 650 | 0.140 |
Why?
|
| New York | 3 | 2007 | 104 | 0.130 |
Why?
|
| Fusion Proteins, gag-pol | 3 | 2013 | 4 | 0.130 |
Why?
|
| DNA | 5 | 1996 | 2693 | 0.130 |
Why?
|
| Mice, Knockout | 6 | 2018 | 5710 | 0.130 |
Why?
|
| Disease Progression | 8 | 2013 | 6682 | 0.130 |
Why?
|
| In Vitro Techniques | 5 | 2010 | 1618 | 0.130 |
Why?
|
| Phenotype | 6 | 2006 | 6295 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 8 | 2018 | 6942 | 0.130 |
Why?
|
| Incidence | 6 | 2015 | 5673 | 0.130 |
Why?
|
| Nephrectomy | 3 | 1989 | 779 | 0.130 |
Why?
|
| DNA Primers | 4 | 2007 | 1399 | 0.130 |
Why?
|
| Retinoic Acid Receptor alpha | 3 | 2012 | 95 | 0.120 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2011 | 1033 | 0.120 |
Why?
|
| Real-Time Polymerase Chain Reaction | 3 | 2013 | 1217 | 0.120 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2018 | 1265 | 0.120 |
Why?
|
| Arterioles | 1 | 1994 | 36 | 0.120 |
Why?
|
| Gentamicins | 2 | 1985 | 90 | 0.120 |
Why?
|
| Receptors, Very Late Antigen | 1 | 1993 | 8 | 0.120 |
Why?
|
| Tetrahydronaphthalenes | 2 | 2012 | 116 | 0.120 |
Why?
|
| Enzyme Inhibitors | 1 | 2001 | 1879 | 0.120 |
Why?
|
| Hemodynamics | 7 | 1998 | 935 | 0.120 |
Why?
|
| Cell Communication | 2 | 2011 | 509 | 0.120 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 1994 | 153 | 0.120 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1994 | 223 | 0.120 |
Why?
|
| Blood Pressure | 10 | 2012 | 1467 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 3 | 2008 | 3101 | 0.120 |
Why?
|
| Ureter | 3 | 2004 | 209 | 0.120 |
Why?
|
| Benzoates | 2 | 2012 | 136 | 0.120 |
Why?
|
| Iohexol | 1 | 2013 | 58 | 0.120 |
Why?
|
| Extracellular Matrix | 3 | 1994 | 554 | 0.120 |
Why?
|
| Skin Diseases | 2 | 1995 | 349 | 0.120 |
Why?
|
| GTPase-Activating Proteins | 1 | 2014 | 126 | 0.120 |
Why?
|
| Protein Binding | 4 | 2010 | 3438 | 0.110 |
Why?
|
| Radioisotope Renography | 2 | 1996 | 4 | 0.110 |
Why?
|
| Protein Interaction Maps | 1 | 2014 | 149 | 0.110 |
Why?
|
| Heptanoic Acids | 3 | 1991 | 96 | 0.110 |
Why?
|
| Female | 36 | 2015 | 141928 | 0.110 |
Why?
|
| Human T-lymphotropic virus 1 | 1 | 1993 | 98 | 0.110 |
Why?
|
| Heparitin Sulfate | 2 | 2008 | 35 | 0.110 |
Why?
|
| Prostaglandins | 3 | 1989 | 77 | 0.110 |
Why?
|
| Proviruses | 3 | 2006 | 21 | 0.110 |
Why?
|
| Mortality | 1 | 2015 | 343 | 0.110 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 3 | 2012 | 234 | 0.110 |
Why?
|
| Myocytes, Cardiac | 1 | 2018 | 764 | 0.110 |
Why?
|
| Atrial Natriuretic Factor | 2 | 1990 | 68 | 0.110 |
Why?
|
| RNA | 3 | 2004 | 1013 | 0.110 |
Why?
|
| Methacrylates | 3 | 1989 | 21 | 0.110 |
Why?
|
| Hepatitis C | 2 | 2008 | 524 | 0.110 |
Why?
|
| Imidazoles | 5 | 1992 | 999 | 0.110 |
Why?
|
| Sarcoma, Experimental | 1 | 1992 | 68 | 0.110 |
Why?
|
| Biphenyl Compounds | 3 | 1991 | 194 | 0.110 |
Why?
|
| Chromosome Mapping | 3 | 2008 | 1471 | 0.110 |
Why?
|
| Energy Metabolism | 1 | 2018 | 992 | 0.110 |
Why?
|
| Nephritis | 1 | 2012 | 36 | 0.110 |
Why?
|
| Femoral Artery | 1 | 2013 | 210 | 0.110 |
Why?
|
| T-Lymphocytes | 4 | 2006 | 3869 | 0.110 |
Why?
|
| Basement Membrane | 3 | 2003 | 138 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2008 | 4938 | 0.100 |
Why?
|
| Phosphodiesterase 4 Inhibitors | 1 | 2012 | 24 | 0.100 |
Why?
|
| Prostaglandin Endoperoxides, Synthetic | 1 | 1991 | 4 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2013 | 2488 | 0.100 |
Why?
|
| Stress, Physiological | 1 | 2015 | 492 | 0.100 |
Why?
|
| Cytoskeletal Proteins | 1 | 2014 | 492 | 0.100 |
Why?
|
| Blotting, Western | 3 | 2013 | 3536 | 0.100 |
Why?
|
| Glomerulonephritis, IGA | 1 | 2011 | 16 | 0.100 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 395 | 0.100 |
Why?
|
| Potassium Chloride | 2 | 1992 | 55 | 0.100 |
Why?
|
| Response Elements | 1 | 2012 | 193 | 0.100 |
Why?
|
| Cloning, Molecular | 2 | 2004 | 1213 | 0.100 |
Why?
|
| Receptor, Notch1 | 1 | 2013 | 218 | 0.100 |
Why?
|
| Dehydration | 1 | 1991 | 87 | 0.100 |
Why?
|
| Cyclopropanes | 2 | 2012 | 88 | 0.100 |
Why?
|
| Renal Veins | 3 | 2002 | 56 | 0.100 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 1399 | 0.100 |
Why?
|
| Cell Transformation, Viral | 1 | 1991 | 138 | 0.100 |
Why?
|
| Ki-67 Antigen | 2 | 2005 | 666 | 0.100 |
Why?
|
| Polycystic Kidney Diseases | 1 | 1991 | 34 | 0.100 |
Why?
|
| Biomarkers | 5 | 2013 | 5047 | 0.100 |
Why?
|
| Creatinine | 5 | 2013 | 531 | 0.100 |
Why?
|
| Transcription, Genetic | 4 | 2008 | 3154 | 0.100 |
Why?
|
| Immunohistochemistry | 7 | 2008 | 7548 | 0.100 |
Why?
|
| Angiography | 2 | 1989 | 360 | 0.100 |
Why?
|
| Heart Auscultation | 1 | 1990 | 10 | 0.100 |
Why?
|
| Physician's Role | 2 | 2011 | 238 | 0.100 |
Why?
|
| Heart Murmurs | 1 | 1990 | 14 | 0.100 |
Why?
|
| Nuclear Proteins | 2 | 2012 | 3343 | 0.100 |
Why?
|
| Aprotinin | 2 | 1987 | 34 | 0.100 |
Why?
|
| Electrophysiology | 2 | 2005 | 333 | 0.100 |
Why?
|
| Veterans | 1 | 2022 | 1641 | 0.100 |
Why?
|
| Wnt Signaling Pathway | 1 | 2013 | 430 | 0.090 |
Why?
|
| Inulin | 5 | 1989 | 20 | 0.090 |
Why?
|
| Guanylate Kinases | 1 | 2010 | 24 | 0.090 |
Why?
|
| Gene Products, tat | 3 | 1995 | 54 | 0.090 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 1995 | 419 | 0.090 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2012 | 270 | 0.090 |
Why?
|
| Epithelium | 3 | 2000 | 720 | 0.090 |
Why?
|
| Aminopyridines | 1 | 2012 | 212 | 0.090 |
Why?
|
| Malpractice | 1 | 2010 | 60 | 0.090 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2010 | 101 | 0.090 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 1 | 2010 | 29 | 0.090 |
Why?
|
| Research Personnel | 1 | 2011 | 156 | 0.090 |
Why?
|
| Lymphocytes | 2 | 1999 | 1234 | 0.090 |
Why?
|
| vpr Gene Products, Human Immunodeficiency Virus | 1 | 2009 | 20 | 0.090 |
Why?
|
| Receptors, Notch | 1 | 2013 | 383 | 0.090 |
Why?
|
| Immunodeficiency Virus, Feline | 1 | 2009 | 17 | 0.090 |
Why?
|
| Rats, Inbred SHR | 1 | 1989 | 113 | 0.090 |
Why?
|
| Lipocalins | 1 | 2009 | 54 | 0.090 |
Why?
|
| International Cooperation | 1 | 2011 | 323 | 0.090 |
Why?
|
| Adipokines | 1 | 2010 | 96 | 0.090 |
Why?
|
| Acute-Phase Proteins | 1 | 2009 | 79 | 0.090 |
Why?
|
| Aorta | 1 | 2013 | 692 | 0.090 |
Why?
|
| Nobel Prize | 1 | 2009 | 9 | 0.090 |
Why?
|
| Career Choice | 1 | 2011 | 232 | 0.090 |
Why?
|
| LLC-PK1 Cells | 1 | 2008 | 9 | 0.090 |
Why?
|
| Malates | 1 | 2008 | 7 | 0.090 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2008 | 40 | 0.090 |
Why?
|
| Receptors, Fibronectin | 3 | 1993 | 25 | 0.090 |
Why?
|
| Epidermal Growth Factor | 1 | 1991 | 423 | 0.090 |
Why?
|
| Mentors | 1 | 2011 | 203 | 0.080 |
Why?
|
| Acrylates | 1 | 1989 | 30 | 0.080 |
Why?
|
| Monocytes | 1 | 1993 | 788 | 0.080 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2013 | 612 | 0.080 |
Why?
|
| Interferon Type I | 1 | 2010 | 250 | 0.080 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 591 | 0.080 |
Why?
|
| Upstream Stimulatory Factors | 1 | 2008 | 11 | 0.080 |
Why?
|
| History, 21st Century | 2 | 2009 | 441 | 0.080 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2008 | 16 | 0.080 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2010 | 203 | 0.080 |
Why?
|
| Capitalism | 1 | 2008 | 1 | 0.080 |
Why?
|
| Single-Payer System | 1 | 2008 | 2 | 0.080 |
Why?
|
| Simian Immunodeficiency Virus | 1 | 2009 | 133 | 0.080 |
Why?
|
| Cell Nucleus | 2 | 2008 | 1620 | 0.080 |
Why?
|
| National Health Insurance, United States | 1 | 2008 | 4 | 0.080 |
Why?
|
| Home Care Services | 1 | 2009 | 92 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2008 | 10 | 0.080 |
Why?
|
| Data Collection | 1 | 2011 | 620 | 0.080 |
Why?
|
| Faculty, Medical | 1 | 2011 | 289 | 0.080 |
Why?
|
| HIV Envelope Protein gp120 | 2 | 2006 | 62 | 0.080 |
Why?
|
| History, 20th Century | 2 | 2009 | 574 | 0.080 |
Why?
|
| Unemployment | 1 | 2008 | 31 | 0.080 |
Why?
|
| Giant Cells | 1 | 2008 | 69 | 0.080 |
Why?
|
| Nifedipine | 1 | 1987 | 25 | 0.080 |
Why?
|
| Genetic Markers | 3 | 2005 | 974 | 0.080 |
Why?
|
| Dependovirus | 2 | 1999 | 135 | 0.080 |
Why?
|
| Dietary Proteins | 1 | 1989 | 241 | 0.080 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2008 | 33 | 0.080 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2008 | 79 | 0.080 |
Why?
|
| Fish Oils | 1 | 1988 | 88 | 0.080 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2008 | 194 | 0.080 |
Why?
|
| Alkynes | 1 | 2007 | 29 | 0.080 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2008 | 107 | 0.080 |
Why?
|
| Medically Uninsured | 1 | 2008 | 102 | 0.080 |
Why?
|
| Gene Expression Profiling | 5 | 2013 | 5159 | 0.080 |
Why?
|
| Quantitative Trait Loci | 1 | 2009 | 374 | 0.080 |
Why?
|
| DNA Replication | 1 | 1991 | 744 | 0.070 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2008 | 116 | 0.070 |
Why?
|
| Tenofovir | 1 | 2007 | 23 | 0.070 |
Why?
|
| Nephrology | 1 | 2009 | 151 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2013 | 2508 | 0.070 |
Why?
|
| Genetic Variation | 2 | 2012 | 2086 | 0.070 |
Why?
|
| Severity of Illness Index | 4 | 2010 | 4320 | 0.070 |
Why?
|
| p-Aminohippuric Acid | 4 | 1988 | 5 | 0.070 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 3 | 1995 | 45 | 0.070 |
Why?
|
| Genes, pol | 1 | 2006 | 8 | 0.070 |
Why?
|
| Genes, gag | 1 | 2006 | 9 | 0.070 |
Why?
|
| Ethiopia | 1 | 2006 | 24 | 0.070 |
Why?
|
| Muscles | 1 | 2008 | 416 | 0.070 |
Why?
|
| Autoradiography | 3 | 1995 | 132 | 0.070 |
Why?
|
| Israel | 1 | 2006 | 53 | 0.070 |
Why?
|
| Binding Sites | 3 | 2005 | 2171 | 0.070 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 2006 | 25 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 694 | 0.070 |
Why?
|
| Paraffin Embedding | 1 | 2007 | 226 | 0.070 |
Why?
|
| Tropism | 1 | 2006 | 19 | 0.070 |
Why?
|
| Benzamides | 1 | 2012 | 1832 | 0.070 |
Why?
|
| Reassortant Viruses | 1 | 2006 | 32 | 0.070 |
Why?
|
| Microscopy, Confocal | 1 | 2008 | 663 | 0.070 |
Why?
|
| Animals, Newborn | 4 | 1995 | 1338 | 0.070 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2006 | 26 | 0.070 |
Why?
|
| HIV Long Terminal Repeat | 2 | 1996 | 24 | 0.070 |
Why?
|
| Staining and Labeling | 2 | 2001 | 429 | 0.070 |
Why?
|
| Dietary Fats | 1 | 1988 | 339 | 0.070 |
Why?
|
| Plasmids | 2 | 2007 | 837 | 0.070 |
Why?
|
| Kidney Cortex | 1 | 1985 | 35 | 0.070 |
Why?
|
| Bradykinin | 1 | 1985 | 79 | 0.070 |
Why?
|
| Hydronephrosis | 1 | 1986 | 50 | 0.070 |
Why?
|
| Patient-Centered Care | 1 | 2009 | 294 | 0.070 |
Why?
|
| Primates | 1 | 2006 | 128 | 0.070 |
Why?
|
| Least-Squares Analysis | 1 | 2005 | 66 | 0.070 |
Why?
|
| Myocardial Contraction | 2 | 2018 | 291 | 0.070 |
Why?
|
| Hepacivirus | 1 | 2008 | 397 | 0.070 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 1991 | 923 | 0.070 |
Why?
|
| Phylogeny | 2 | 2009 | 826 | 0.070 |
Why?
|
| Proteoglycans | 2 | 1998 | 259 | 0.060 |
Why?
|
| Allosteric Regulation | 1 | 2005 | 68 | 0.060 |
Why?
|
| Biological Transport, Active | 1 | 2005 | 131 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2009 | 1533 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2005 | 611 | 0.060 |
Why?
|
| Gene Deletion | 2 | 2013 | 1442 | 0.060 |
Why?
|
| Regional Blood Flow | 4 | 1994 | 276 | 0.060 |
Why?
|
| Transcription Factors | 3 | 2012 | 5270 | 0.060 |
Why?
|
| Age Factors | 2 | 2007 | 5377 | 0.060 |
Why?
|
| Models, Chemical | 1 | 2005 | 186 | 0.060 |
Why?
|
| Dimerization | 1 | 2005 | 304 | 0.060 |
Why?
|
| Nephrosclerosis | 2 | 2008 | 13 | 0.060 |
Why?
|
| Adipose Tissue | 1 | 2010 | 769 | 0.060 |
Why?
|
| Swine | 1 | 2008 | 1541 | 0.060 |
Why?
|
| Substrate Specificity | 2 | 2004 | 549 | 0.060 |
Why?
|
| Nepovirus | 1 | 2004 | 1 | 0.060 |
Why?
|
| Protein Structure, Secondary | 1 | 2005 | 336 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2008 | 1764 | 0.060 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 2000 | 132 | 0.060 |
Why?
|
| Immunoglobulins | 1 | 2005 | 266 | 0.060 |
Why?
|
| Antihypertensive Agents | 3 | 2012 | 395 | 0.060 |
Why?
|
| Neprilysin | 1 | 2003 | 66 | 0.060 |
Why?
|
| Chromatography, Affinity | 2 | 2002 | 122 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 3 | 1999 | 1165 | 0.060 |
Why?
|
| Hypertrophy | 2 | 1994 | 162 | 0.060 |
Why?
|
| Bicarbonates | 1 | 1983 | 130 | 0.060 |
Why?
|
| Population Surveillance | 1 | 2007 | 627 | 0.060 |
Why?
|
| Sialoglycoproteins | 1 | 2003 | 151 | 0.060 |
Why?
|
| Growth Disorders | 2 | 1996 | 218 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2010 | 1586 | 0.060 |
Why?
|
| Aged | 12 | 2013 | 70117 | 0.060 |
Why?
|
| Mice, Inbred Strains | 3 | 2013 | 521 | 0.060 |
Why?
|
| Sensitivity and Specificity | 6 | 2006 | 4971 | 0.060 |
Why?
|
| Renal Dialysis | 3 | 2000 | 945 | 0.060 |
Why?
|
| Viral Load | 2 | 2002 | 493 | 0.060 |
Why?
|
| Vasoconstriction | 2 | 1996 | 104 | 0.060 |
Why?
|
| Oxidation-Reduction | 2 | 2018 | 717 | 0.060 |
Why?
|
| Rats, Inbred ACI | 5 | 1990 | 11 | 0.050 |
Why?
|
| Hippocratic Oath | 1 | 2002 | 6 | 0.050 |
Why?
|
| Age Distribution | 2 | 2001 | 698 | 0.050 |
Why?
|
| Diagnosis, Differential | 3 | 2002 | 4744 | 0.050 |
Why?
|
| Prognosis | 5 | 2015 | 21713 | 0.050 |
Why?
|
| Gene Products, env | 1 | 2002 | 38 | 0.050 |
Why?
|
| Cyclin E | 1 | 2004 | 267 | 0.050 |
Why?
|
| Forecasting | 1 | 2005 | 694 | 0.050 |
Why?
|
| Injections, Intra-Arterial | 1 | 2002 | 62 | 0.050 |
Why?
|
| Homozygote | 2 | 1995 | 717 | 0.050 |
Why?
|
| Eicosanoids | 3 | 1990 | 31 | 0.050 |
Why?
|
| Acute Kidney Injury | 2 | 2008 | 739 | 0.050 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 1993 | 360 | 0.050 |
Why?
|
| Nucleic Acid Conformation | 2 | 2004 | 279 | 0.050 |
Why?
|
| Leucine | 1 | 2003 | 352 | 0.050 |
Why?
|
| Kidney Function Tests | 4 | 1996 | 192 | 0.050 |
Why?
|
| DNA Damage | 1 | 2009 | 1954 | 0.050 |
Why?
|
| Prednisone | 1 | 2004 | 984 | 0.050 |
Why?
|
| Axons | 1 | 2004 | 403 | 0.050 |
Why?
|
| Drug Therapy, Combination | 3 | 2013 | 2315 | 0.050 |
Why?
|
| Minoxidil | 2 | 1979 | 8 | 0.050 |
Why?
|
| Survival Analysis | 4 | 2011 | 9180 | 0.050 |
Why?
|
| Clone Cells | 1 | 2002 | 555 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2005 | 785 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2002 | 585 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2002 | 274 | 0.050 |
Why?
|
| Genetic Engineering | 2 | 2004 | 288 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2004 | 461 | 0.050 |
Why?
|
| Tissue Fixation | 1 | 2001 | 136 | 0.050 |
Why?
|
| Hospital Mortality | 2 | 2022 | 1274 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2008 | 1270 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2005 | 1152 | 0.050 |
Why?
|
| Sex Distribution | 1 | 2001 | 495 | 0.050 |
Why?
|
| Receptors, Prostaglandin | 2 | 1990 | 29 | 0.040 |
Why?
|
| Clinical Trials as Topic | 2 | 2007 | 3719 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2002 | 844 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 1487 | 0.040 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2000 | 448 | 0.040 |
Why?
|
| Transcription Factor RelA | 1 | 2020 | 184 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2005 | 1555 | 0.040 |
Why?
|
| Transplantation Immunology | 1 | 1999 | 97 | 0.040 |
Why?
|
| Mitogens | 1 | 1999 | 75 | 0.040 |
Why?
|
| Cell Polarity | 1 | 2000 | 208 | 0.040 |
Why?
|
| Subtraction Technique | 2 | 1989 | 141 | 0.040 |
Why?
|
| Ligands | 2 | 2013 | 995 | 0.040 |
Why?
|
| HIV Seropositivity | 1 | 2020 | 144 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2006 | 1546 | 0.040 |
Why?
|
| Aging | 3 | 2005 | 1582 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 2002 | 2314 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2003 | 891 | 0.040 |
Why?
|
| Radioimmunoassay | 2 | 1991 | 191 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2007 | 2594 | 0.040 |
Why?
|
| Heterozygote | 2 | 2008 | 1020 | 0.040 |
Why?
|
| False Positive Reactions | 2 | 2006 | 355 | 0.040 |
Why?
|
| NFATC Transcription Factors | 1 | 2018 | 96 | 0.040 |
Why?
|
| Cats | 1 | 1998 | 166 | 0.040 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2018 | 133 | 0.040 |
Why?
|
| Chromosomes | 2 | 2009 | 244 | 0.040 |
Why?
|
| DNA Modification Methylases | 1 | 2018 | 172 | 0.040 |
Why?
|
| Endothelin-1 | 1 | 1998 | 60 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2018 | 181 | 0.040 |
Why?
|
| Education, Medical | 1 | 2002 | 331 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2018 | 208 | 0.040 |
Why?
|
| Drug Evaluation | 1 | 1998 | 425 | 0.040 |
Why?
|
| Enalapril | 2 | 1996 | 20 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 276 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2007 | 4314 | 0.040 |
Why?
|
| Cell Hypoxia | 1 | 2018 | 328 | 0.040 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 2 | 1996 | 43 | 0.040 |
Why?
|
| Thymidine | 2 | 2001 | 155 | 0.040 |
Why?
|
| Macrophages | 3 | 2010 | 1304 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2009 | 272 | 0.040 |
Why?
|
| Metabolic Clearance Rate | 2 | 1988 | 231 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 1999 | 396 | 0.040 |
Why?
|
| Hospitalization | 2 | 2022 | 2083 | 0.040 |
Why?
|
| Crosses, Genetic | 2 | 2009 | 241 | 0.040 |
Why?
|
| Arachidonic Acid | 2 | 1988 | 118 | 0.040 |
Why?
|
| Spleen | 3 | 1994 | 676 | 0.040 |
Why?
|
| Vascular Resistance | 3 | 1990 | 200 | 0.040 |
Why?
|
| Biological Transport | 1 | 1998 | 597 | 0.040 |
Why?
|
| Genes, tat | 1 | 1996 | 12 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2020 | 651 | 0.030 |
Why?
|
| Pulmonary Circulation | 1 | 1977 | 131 | 0.030 |
Why?
|
| Kinetics | 2 | 1991 | 2049 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2018 | 545 | 0.030 |
Why?
|
| Deoxyribonuclease I | 2 | 1992 | 67 | 0.030 |
Why?
|
| Random Allocation | 2 | 1987 | 703 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 14551 | 0.030 |
Why?
|
| AIDS Dementia Complex | 1 | 1995 | 18 | 0.030 |
Why?
|
| Electrophoresis | 1 | 1995 | 60 | 0.030 |
Why?
|
| Renal Replacement Therapy | 2 | 2009 | 135 | 0.030 |
Why?
|
| Prospective Studies | 5 | 2008 | 12873 | 0.030 |
Why?
|
| Membrane Potentials | 1 | 1996 | 424 | 0.030 |
Why?
|
| Protease Inhibitors | 1 | 1996 | 210 | 0.030 |
Why?
|
| Genes, Homeobox | 1 | 1995 | 147 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 1995 | 122 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 1997 | 575 | 0.030 |
Why?
|
| Heart Rate | 5 | 1988 | 737 | 0.030 |
Why?
|
| United Kingdom | 1 | 2015 | 257 | 0.030 |
Why?
|
| Logistic Models | 1 | 2022 | 3441 | 0.030 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1995 | 90 | 0.030 |
Why?
|
| rap GTP-Binding Proteins | 1 | 2014 | 5 | 0.030 |
Why?
|
| Embryonic and Fetal Development | 1 | 1995 | 205 | 0.030 |
Why?
|
| Ventricular Function, Left | 1 | 2018 | 603 | 0.030 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 1994 | 64 | 0.030 |
Why?
|
| Rats, Inbred WKY | 2 | 1996 | 110 | 0.030 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 1994 | 24 | 0.030 |
Why?
|
| Leukotriene Antagonists | 1 | 1994 | 16 | 0.030 |
Why?
|
| Paraparesis, Tropical Spastic | 1 | 1993 | 7 | 0.030 |
Why?
|
| Leukotriene B4 | 1 | 1994 | 20 | 0.030 |
Why?
|
| rap1 GTP-Binding Proteins | 1 | 2014 | 32 | 0.030 |
Why?
|
| Retroviridae Proteins, Oncogenic | 1 | 1993 | 36 | 0.030 |
Why?
|
| Isomerism | 1 | 1993 | 63 | 0.030 |
Why?
|
| Integrin alpha4beta1 | 1 | 1993 | 45 | 0.030 |
Why?
|
| Double-Blind Method | 3 | 1992 | 2588 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1994 | 226 | 0.030 |
Why?
|
| Kenya | 1 | 2013 | 46 | 0.030 |
Why?
|
| Receptors, HIV | 1 | 1993 | 4 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 987 | 0.030 |
Why?
|
| Integrin beta1 | 1 | 2014 | 126 | 0.030 |
Why?
|
| Dibenzazepines | 1 | 2013 | 4 | 0.030 |
Why?
|
| Neurons | 1 | 2004 | 2287 | 0.030 |
Why?
|
| Receptor, Notch4 | 1 | 2013 | 13 | 0.030 |
Why?
|
| Survival Rate | 2 | 2015 | 12221 | 0.030 |
Why?
|
| Research Design | 2 | 2011 | 1544 | 0.030 |
Why?
|
| Receptors, Thromboxane | 2 | 1990 | 7 | 0.030 |
Why?
|
| Sarcoma, Kaposi | 1 | 1995 | 187 | 0.030 |
Why?
|
| Sclerosis | 1 | 2013 | 84 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2000 | 1863 | 0.030 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 1993 | 54 | 0.030 |
Why?
|
| Predictive Value of Tests | 3 | 2011 | 4892 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2010 | 2927 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 1995 | 613 | 0.030 |
Why?
|
| Cataract | 1 | 1995 | 218 | 0.030 |
Why?
|
| Teratoma | 2 | 1991 | 236 | 0.030 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 1995 | 234 | 0.030 |
Why?
|
| Smoking | 1 | 2022 | 2440 | 0.030 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2013 | 99 | 0.030 |
Why?
|
| Blood Vessels | 1 | 1993 | 217 | 0.030 |
Why?
|
| Dipeptides | 1 | 2013 | 91 | 0.030 |
Why?
|
| Benzazepines | 1 | 2013 | 108 | 0.030 |
Why?
|
| Cell Dedifferentiation | 1 | 2013 | 96 | 0.030 |
Why?
|
| Molecular Probes | 1 | 1992 | 72 | 0.030 |
Why?
|
| Haploinsufficiency | 1 | 2014 | 294 | 0.030 |
Why?
|
| Collagen Type IV | 1 | 2013 | 108 | 0.030 |
Why?
|
| Glucose | 1 | 2018 | 1248 | 0.030 |
Why?
|
| Genes, Reporter | 2 | 2008 | 798 | 0.030 |
Why?
|
| Iodohippuric Acid | 1 | 1991 | 2 | 0.030 |
Why?
|
| Oncogenes | 1 | 1995 | 673 | 0.030 |
Why?
|
| Technetium Tc 99m Pentetate | 1 | 1991 | 14 | 0.030 |
Why?
|
| Pregnancy | 2 | 1996 | 7573 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2012 | 66 | 0.030 |
Why?
|
| Smad3 Protein | 1 | 2013 | 129 | 0.030 |
Why?
|
| Natriuresis | 1 | 1992 | 43 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2018 | 1129 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 2483 | 0.030 |
Why?
|
| Bridged Bicyclo Compounds | 1 | 1991 | 5 | 0.030 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 1991 | 37 | 0.030 |
Why?
|
| Chromatin | 1 | 1997 | 942 | 0.030 |
Why?
|
| CREB-Binding Protein | 1 | 2012 | 86 | 0.030 |
Why?
|
| Clinical Enzyme Tests | 1 | 1991 | 25 | 0.020 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 1991 | 94 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 1995 | 862 | 0.020 |
Why?
|
| Hydroxysteroid Dehydrogenases | 1 | 2010 | 19 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 1991 | 293 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 1991 | 157 | 0.020 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2010 | 45 | 0.020 |
Why?
|
| Amino Acid Isomerases | 1 | 1990 | 8 | 0.020 |
Why?
|
| Cyclosporine | 1 | 1992 | 278 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2011 | 1819 | 0.020 |
Why?
|
| Cost Control | 1 | 2010 | 48 | 0.020 |
Why?
|
| Placenta | 1 | 1995 | 516 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 1994 | 875 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 423 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2012 | 32848 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2013 | 442 | 0.020 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 1990 | 73 | 0.020 |
Why?
|
| Hyperplasia | 1 | 1991 | 557 | 0.020 |
Why?
|
| Public Policy | 1 | 2010 | 60 | 0.020 |
Why?
|
| Retinoids | 1 | 2010 | 164 | 0.020 |
Why?
|
| Policy Making | 1 | 2010 | 85 | 0.020 |
Why?
|
| Infant | 3 | 1994 | 13310 | 0.020 |
Why?
|
| Genome, Human | 1 | 2018 | 1869 | 0.020 |
Why?
|
| Cell Cycle | 2 | 2009 | 2084 | 0.020 |
Why?
|
| Iodine Radioisotopes | 1 | 1991 | 371 | 0.020 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 1 | 1989 | 10 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1990 | 418 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 1999 | 2045 | 0.020 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2010 | 94 | 0.020 |
Why?
|
| Aminohippuric Acids | 1 | 1989 | 2 | 0.020 |
Why?
|
| Subcutaneous Tissue | 1 | 2010 | 62 | 0.020 |
Why?
|
| Polysaccharides | 1 | 2011 | 197 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2013 | 1313 | 0.020 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 1989 | 8 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 1991 | 309 | 0.020 |
Why?
|
| Ligation | 1 | 1990 | 193 | 0.020 |
Why?
|
| Politics | 1 | 2010 | 74 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2008 | 9244 | 0.020 |
Why?
|
| Blue Cross Blue Shield Insurance Plans | 1 | 2009 | 3 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 1994 | 1681 | 0.020 |
Why?
|
| Phosphoinositide Phospholipase C | 1 | 2009 | 13 | 0.020 |
Why?
|
| Lipocalin-2 | 1 | 2009 | 65 | 0.020 |
Why?
|
| Steroid Hydroxylases | 1 | 1989 | 36 | 0.020 |
Why?
|
| Renal Artery | 1 | 1989 | 79 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2011 | 626 | 0.020 |
Why?
|
| Fibrosis | 1 | 2013 | 793 | 0.020 |
Why?
|
| Body Weight | 1 | 1994 | 1293 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1991 | 467 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2012 | 1163 | 0.020 |
Why?
|
| Mice, Congenic | 1 | 2008 | 30 | 0.020 |
Why?
|
| Haplotypes | 1 | 2011 | 856 | 0.020 |
Why?
|
| Peptides | 2 | 1994 | 1479 | 0.020 |
Why?
|
| Indinavir | 1 | 2008 | 8 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2010 | 155 | 0.020 |
Why?
|
| CD4 Antigens | 1 | 2009 | 170 | 0.020 |
Why?
|
| Adiponectin | 1 | 2010 | 163 | 0.020 |
Why?
|
| Physicians, Family | 1 | 2009 | 54 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2010 | 203 | 0.020 |
Why?
|
| Subcutaneous Fat | 1 | 2010 | 92 | 0.020 |
Why?
|
| Adipogenesis | 1 | 2010 | 105 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 1993 | 5395 | 0.020 |
Why?
|
| Infusions, Intra-Arterial | 1 | 1989 | 171 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2022 | 37905 | 0.020 |
Why?
|
| Weight Loss | 1 | 2013 | 627 | 0.020 |
Why?
|
| Diuretics | 2 | 1987 | 170 | 0.020 |
Why?
|
| Prazosin | 1 | 1988 | 22 | 0.020 |
Why?
|
| Prostaglandins F | 1 | 1988 | 9 | 0.020 |
Why?
|
| HIV Protease Inhibitors | 1 | 2008 | 72 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2018 | 2669 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2011 | 4549 | 0.020 |
Why?
|
| Fats | 1 | 1988 | 16 | 0.020 |
Why?
|
| Public Health | 1 | 2011 | 299 | 0.020 |
Why?
|
| Benzothiadiazines | 1 | 1987 | 5 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2006 | 709 | 0.020 |
Why?
|
| Graft Enhancement, Immunologic | 1 | 1988 | 37 | 0.020 |
Why?
|
| Leptin | 1 | 2010 | 295 | 0.020 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 1 | 1987 | 31 | 0.020 |
Why?
|
| Pyrimidines | 2 | 1979 | 3518 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2011 | 672 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 1991 | 3033 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2009 | 512 | 0.020 |
Why?
|
| Food, Fortified | 1 | 1988 | 95 | 0.020 |
Why?
|
| Major Histocompatibility Complex | 1 | 2007 | 91 | 0.020 |
Why?
|
| Delayed-Action Preparations | 1 | 1987 | 208 | 0.020 |
Why?
|
| Morbidity | 1 | 2008 | 397 | 0.020 |
Why?
|
| Reference Values | 1 | 1989 | 1099 | 0.020 |
Why?
|
| Thrombosis | 1 | 1994 | 781 | 0.020 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 1989 | 1016 | 0.020 |
Why?
|
| Cytomegalovirus | 1 | 1990 | 482 | 0.020 |
Why?
|
| Transplantation, Isogeneic | 1 | 1986 | 56 | 0.020 |
Why?
|
| Coronary Circulation | 1 | 1987 | 253 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 1986 | 113 | 0.020 |
Why?
|
| Receptors, CCR3 | 1 | 2006 | 5 | 0.020 |
Why?
|
| Receptors, CXCR6 | 1 | 2006 | 16 | 0.020 |
Why?
|
| Prostaglandins E | 1 | 1986 | 23 | 0.020 |
Why?
|
| Radiographic Image Enhancement | 1 | 1989 | 402 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 1991 | 1688 | 0.020 |
Why?
|
| Antigens, CD | 1 | 1991 | 1385 | 0.020 |
Why?
|
| Quinacrine | 1 | 1985 | 7 | 0.020 |
Why?
|
| Medicaid | 1 | 2009 | 279 | 0.020 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 1999 | 182 | 0.020 |
Why?
|
| Placebos | 1 | 1987 | 437 | 0.020 |
Why?
|
| Oligomycins | 1 | 1985 | 9 | 0.020 |
Why?
|
| Antimycin A | 1 | 1985 | 13 | 0.020 |
Why?
|
| Rotenone | 1 | 1985 | 35 | 0.020 |
Why?
|
| Cytomegalovirus Infections | 1 | 1990 | 462 | 0.020 |
Why?
|
| Chimerism | 1 | 2006 | 63 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2010 | 677 | 0.020 |
Why?
|
| Receptors, Chemokine | 1 | 2006 | 114 | 0.020 |
Why?
|
| Radiography | 1 | 1990 | 1904 | 0.020 |
Why?
|
| Indomethacin | 1 | 1985 | 91 | 0.020 |
Why?
|
| Receptors, Virus | 1 | 2006 | 157 | 0.020 |
Why?
|
| Receptors, Cytokine | 1 | 2006 | 176 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2010 | 1038 | 0.020 |
Why?
|
| Family | 1 | 2009 | 736 | 0.020 |
Why?
|
| Dinoprostone | 1 | 1986 | 208 | 0.020 |
Why?
|
| Pyridines | 1 | 1992 | 1244 | 0.020 |
Why?
|
| Aminoglycosides | 1 | 1985 | 220 | 0.020 |
Why?
|
| Heart Diseases | 1 | 2011 | 732 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 1538 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2011 | 1335 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 1988 | 583 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2010 | 792 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 622 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2008 | 769 | 0.020 |
Why?
|
| Templates, Genetic | 1 | 2004 | 86 | 0.020 |
Why?
|
| Rabbits | 1 | 1985 | 957 | 0.020 |
Why?
|
| Medicare | 1 | 2009 | 860 | 0.020 |
Why?
|
| Lipids | 1 | 1988 | 644 | 0.010 |
Why?
|
| Absorption | 1 | 1983 | 81 | 0.010 |
Why?
|
| Risk | 1 | 2008 | 1972 | 0.010 |
Why?
|
| Adenine Nucleotides | 1 | 1985 | 351 | 0.010 |
Why?
|
| Catalysis | 1 | 2004 | 250 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 1994 | 2967 | 0.010 |
Why?
|
| Inflammation | 3 | 2008 | 2522 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2009 | 761 | 0.010 |
Why?
|
| Humanism | 1 | 2002 | 6 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1999 | 1062 | 0.010 |
Why?
|
| Ethics, Professional | 1 | 2002 | 26 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 6009 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2012 | 6100 | 0.010 |
Why?
|
| Cardiac Output | 2 | 1987 | 194 | 0.010 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2006 | 488 | 0.010 |
Why?
|
| Altruism | 1 | 2002 | 34 | 0.010 |
Why?
|
| House Calls | 1 | 2002 | 39 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 2216 | 0.010 |
Why?
|
| Social Responsibility | 1 | 2002 | 92 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 4988 | 0.010 |
Why?
|
| Transplantation, Homologous | 3 | 1999 | 2843 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1990 | 2022 | 0.010 |
Why?
|
| Agar | 1 | 2001 | 26 | 0.010 |
Why?
|
| Adolescent | 2 | 2013 | 31252 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 1987 | 3472 | 0.010 |
Why?
|
| DNA, Circular | 1 | 2001 | 34 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2005 | 544 | 0.010 |
Why?
|
| Gene Products, pol | 1 | 2000 | 8 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2001 | 260 | 0.010 |
Why?
|
| Gene Products, gag | 1 | 2000 | 36 | 0.010 |
Why?
|
| Culture Media | 1 | 2001 | 319 | 0.010 |
Why?
|
| Teaching | 1 | 2002 | 243 | 0.010 |
Why?
|
| Interpersonal Relations | 1 | 2002 | 290 | 0.010 |
Why?
|
| Lac Operon | 1 | 1999 | 122 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2013 | 2947 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2001 | 562 | 0.010 |
Why?
|
| Isoantigens | 1 | 1999 | 62 | 0.010 |
Why?
|
| Aldosterone | 1 | 1979 | 72 | 0.010 |
Why?
|
| Phorbol Esters | 1 | 1999 | 39 | 0.010 |
Why?
|
| A Kinase Anchor Proteins | 1 | 1999 | 22 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2011 | 5687 | 0.010 |
Why?
|
| Informed Consent | 1 | 2002 | 419 | 0.010 |
Why?
|
| Mitochondria | 1 | 1985 | 1282 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 1450 | 0.010 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 1999 | 235 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 1985 | 3001 | 0.010 |
Why?
|
| Sodium | 1 | 1979 | 353 | 0.010 |
Why?
|
| Plasminogen Activators | 1 | 1996 | 52 | 0.010 |
Why?
|
| Water-Electrolyte Balance | 1 | 1977 | 104 | 0.010 |
Why?
|
| Leukocyte Common Antigens | 1 | 1997 | 188 | 0.010 |
Why?
|
| Curriculum | 1 | 2002 | 860 | 0.010 |
Why?
|
| Liposomes | 1 | 1998 | 684 | 0.010 |
Why?
|
| Genotype | 1 | 2004 | 4109 | 0.010 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1994 | 48 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 21445 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 3639 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 1994 | 95 | 0.010 |
Why?
|
| Dicarboxylic Acids | 1 | 1994 | 33 | 0.010 |
Why?
|
| Viremia | 1 | 1994 | 177 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 1996 | 598 | 0.010 |
Why?
|
| PC12 Cells | 1 | 1993 | 46 | 0.010 |
Why?
|
| Thymus Gland | 1 | 1994 | 294 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1987 | 14889 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1993 | 568 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1991 | 264 | 0.010 |
Why?
|
| Central Nervous System | 1 | 1994 | 436 | 0.010 |
Why?
|
| Oligopeptides | 1 | 1994 | 429 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 1994 | 584 | 0.010 |
Why?
|
| Internship and Residency | 1 | 2002 | 1375 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 1996 | 1945 | 0.010 |
Why?
|
| Colon | 1 | 1994 | 670 | 0.010 |
Why?
|
| Introns | 1 | 1991 | 432 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1990 | 82 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1990 | 130 | 0.010 |
Why?
|
| Graft Survival | 1 | 1994 | 1062 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1991 | 886 | 0.010 |
Why?
|
| Salivary Glands | 1 | 1990 | 130 | 0.010 |
Why?
|
| Child | 2 | 2005 | 29154 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1990 | 542 | 0.010 |
Why?
|
| Calcitriol | 1 | 1989 | 127 | 0.010 |
Why?
|
| Doxazosin | 1 | 1988 | 32 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 1990 | 475 | 0.010 |
Why?
|
| Indoles | 1 | 1994 | 1009 | 0.000 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1989 | 675 | 0.000 |
Why?
|
| Norepinephrine | 1 | 1988 | 272 | 0.000 |
Why?
|
| Microspheres | 1 | 1987 | 210 | 0.000 |
Why?
|
| Chromosome Deletion | 1 | 1991 | 1005 | 0.000 |
Why?
|
| Gene Amplification | 1 | 1990 | 731 | 0.000 |
Why?
|
| Vitamin D | 1 | 1989 | 261 | 0.000 |
Why?
|
| Dogs | 1 | 1987 | 1155 | 0.000 |
Why?
|
| Immunity, Cellular | 1 | 1987 | 419 | 0.000 |
Why?
|
| Lung | 1 | 1994 | 3151 | 0.000 |
Why?
|
| Coronary Vessels | 1 | 1987 | 665 | 0.000 |
Why?
|
| Preoperative Care | 1 | 1988 | 1529 | 0.000 |
Why?
|
| Blood Volume | 1 | 1979 | 100 | 0.000 |
Why?
|
| Propranolol | 1 | 1979 | 156 | 0.000 |
Why?
|
| Potassium | 1 | 1979 | 329 | 0.000 |
Why?
|
| Child, Preschool | 1 | 1994 | 16273 | 0.000 |
Why?
|